Skip to content
CancerIndex

Loading the knowledge graph…

A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma — knowledge graph · CancerIndex